Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins.

Akache B, Deschatelets L, Harrison BA, Dudani R, Stark FC, Jia Y, Landi A, Law JLM, Logan M, Hockman D, Kundu J, Tyrrell DL, Krishnan L, Houghton M, McCluskie MJ.

Vaccines (Basel). 2019 Dec 3;7(4). pii: E204. doi: 10.3390/vaccines7040204.

2.

Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.

Stark FC, Agbayani G, Sandhu JK, Akache B, McPherson C, Deschatelets L, Dudani R, Hewitt M, Jia Y, Krishnan L, McCluskie MJ.

Biomedicines. 2019 Nov 23;7(4). pii: E91. doi: 10.3390/biomedicines7040091.

3.

Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.

Stark FC, Akache B, Ponce A, Dudani R, Deschatelets L, Jia Y, Sauvageau J, Williams D, Jamshidi MP, Agbayani G, Wachholz K, Harrison BA, Li X, Krishnan L, Chen W, McCluskie MJ.

Vaccine. 2019 Nov 8;37(47):7108-7116. doi: 10.1016/j.vaccine.2019.07.010. Epub 2019 Aug 2.

4.

A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.

Jia Y, Akache B, Deschatelets L, Qian H, Dudani R, Harrison BA, Stark FC, Chandan V, Jamshidi MP, Krishnan L, McCluskie MJ.

Int J Pharm. 2019 Apr 20;561:187-196. doi: 10.1016/j.ijpharm.2019.02.041. Epub 2019 Mar 2.

PMID:
30836154
5.

Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.

Akache B, Stark FC, Jia Y, Deschatelets L, Dudani R, Harrison BA, Agbayani G, Williams D, Jamshidi MP, Krishnan L, McCluskie MJ.

PLoS One. 2018 Dec 4;13(12):e0208067. doi: 10.1371/journal.pone.0208067. eCollection 2018.

6.

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma.

Stark FC, Weeratna RD, Deschatelets L, Gurnani K, Dudani R, McCluskie MJ, Krishnan L.

Vaccines (Basel). 2017 Oct 26;5(4). pii: E38. doi: 10.3390/vaccines5040038.

7.

Intrinsic role of FoxO3a in the development of CD8+ T cell memory.

Tzelepis F, Joseph J, Haddad EK, Maclean S, Dudani R, Agenes F, Peng SL, Sekaly RP, Sad S.

J Immunol. 2013 Feb 1;190(3):1066-75. doi: 10.4049/jimmunol.1200639. Epub 2012 Dec 31.

8.

Modulation of antigenic location converts chronic into acute infection by forcing CD8+ T cell recognition.

Tzelepis F, Alcon V, Dudani R, Gurnani K, Zafer A, Everson ES, Young KG, Rüssmann H, Krishnan L, Sad S.

Cell Rep. 2012 Dec 27;2(6):1710-21. doi: 10.1016/j.celrep.2012.10.024. Epub 2012 Dec 6.

9.

Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium.

Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S.

Nat Immunol. 2012 Oct;13(10):954-62. doi: 10.1038/ni.2397. Epub 2012 Aug 26.

10.

CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system.

Young KG, Maclean S, Dudani R, Krishnan L, Sad S.

J Immunol. 2011 Aug 1;187(3):1192-200. doi: 10.4049/jimmunol.1100695. Epub 2011 Jun 29.

11.

IFN-gamma expressed by T cells regulates the persistence of antigen presentation by limiting the survival of dendritic cells.

Russell MS, Dudani R, Krishnan L, Sad S.

J Immunol. 2009 Dec 15;183(12):7710-8. doi: 10.4049/jimmunol.0901274.

12.
13.

Pathogen proliferation governs the magnitude but compromises the function of CD8 T cells.

Sad S, Dudani R, Gurnani K, Russell M, van Faassen H, Finlay B, Krishnan L.

J Immunol. 2008 May 1;180(9):5853-61.

14.

Mutation in the Fas pathway impairs CD8+ T cell memory.

Dudani R, Russell M, van Faassen H, Krishnan L, Sad S.

J Immunol. 2008 Mar 1;180(5):2933-41.

15.

Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium.

Luu RA, Gurnani K, Dudani R, Kammara R, van Faassen H, Sirard JC, Krishnan L, Sad S.

J Immunol. 2006 Aug 1;177(3):1516-25.

16.
17.
18.

Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: a heterologous bacterial model of attrition.

Smith DK, Dudani R, Pedras-Vasconcelos JA, Chapdelaine Y, van Faassen H, Sad S.

J Immunol. 2002 Aug 1;169(3):1197-206.

19.

Supplemental Content

Loading ...
Support Center